Shopping Cart 0
Cart Subtotal
AED 0

Oregon Health & Science University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Oregon Health & Science University (OHSU), a subsidiary of Oregon State University is an academic health center that provides medical education, research, patient care and community services. The center's educational institute offers undergraduate and graduate courses in anesthesiology, dermatology, neurology, psychiatry, periodontology and nursing. It grants doctoral degrees in medicine, dentistry and nursing. OHSU provides healthcare services such as bone and joint care, cancer care, heart care, neuroscience, pediatrics, spine care and women's health, among others. OHSU conducts research in disease areas including cancer, rare genetic disorders, diseases of the central nervous system, cardiovascular-related research and infectious disease. The center has campuses in Beaverton and Scappoose. OHSU is headquartered in Portland, Oregon, the US.

Oregon Health & Science University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Oregon Health & Science University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Oregon Health & Science University, Medical Devices Deals, 2012 to YTD 2018 10

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

MediciNova Enters into Agreement with US Department of Veterans and Oregon Health & Science 12

Vir Biotechnology Expands Agreement with Oregon Health & Science University 13

NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 14

OncoResponse Enters into Agreement with OHSU Knight Cancer Institute 15

Cancer Research UK Enters into Research Agreement with OHSU Knight Cancer Institute 16

Immunovia Partners with OHSU Knight Cancer Institute 17

Salem Health to Form Joint Venture with Oregon Health & Science University 18

Oregon Health Enters Into Co-Development Agreement With Intel 19

Organovo Enters Into Co-Development Agreement With OHSU Knight Cancer Institute For Cancer Research 20

Legacy Health System Partners OHSU Knight Cancer Institute 21

Licensing Agreements 22

Quickbeam Enters into Licensing Agreement with Oregon Health & Science University 22

Fennec Pharma Amends Licensing Agreement with Oregon Health & Science University 23

Oregon Health & Science University-Key Competitors 24

Oregon Health & Science University-Key Employees 25

Oregon Health & Science University-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Joint Venture 27

Recent Developments 28

Government and Public Interest 28

Sep 06, 2018: NIH taps OHSU to help improve reproductive health 28

Sep 04, 2018: Antioxidant reduces risk for second heart attack, stroke 29

May 25, 2018: OHSU awarded USD 6.1 million to help improve quality of life for those with chronic lung infection 30

May 23, 2018: Foundation for Anesthesia Education and Research Awards USD 1.4 million in Grants 31

May 02, 2018: AI better than most human experts at detecting cause of preemie blindness 34

Apr 09, 2018: An advance for precision medicine 36

Mar 06, 2018: Moving toward a future free of drug-induced hearing loss 37

Jan 17, 2018: Zika virus damages placenta, which may explain malformed babies 38

Oct 27, 2017: Johns Hopkins Partnering with Other Institutions to Create a National Center for Health Data 39

Oct 10, 2017: National MS Society Commits Nearly USD 14 Million to New Research to Stop Multiple Sclerosis, Restore Function and End MS Forever 40

Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 41

Sep 18, 2017: Study uncovers markers for severe form of multiple sclerosis 42

Sep 15, 2017: New funding to unite transatlantic forces for the early detection of cancer 43

Aug 02, 2017: Study in Nature demonstrates method for repairing genes in human embryos that prevents inherited diseases 44

May 08, 2017: BrightFocus Foundation Honors Five Researchers on Macular Degeneration and Glaucoma 46

Jan 30, 2017: New genome-mapping technique opens new avenues for precision medicine 47

Other Significant Developments 48

Sep 12, 2018: GE Healthcare to expand OHSU mission control capabilities to support sepsis patient care 48

May 28, 2018: Scientists expand genetic screening to include rare medical disorders 49

May 16, 2018: OHSU, UCF launch first U.S. clinical trial of 3D-printed prosthetics for children 50

Oct 18, 2017: Patients with Serious Mental Health Conditions Receive Preventive Care at Rates Similar to Those Without These Conditions 52

Appendix 53

Methodology 53

About GlobalData 53

Contact Us 53

Disclaimer 53


List Of Figure

List of Figures

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Oregon Health & Science University, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Oregon Health & Science University, Pharmaceuticals & Healthcare, Key Facts 2

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Oregon Health & Science University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Oregon Health & Science University, Deals By Therapy Area, 2012 to YTD 2018 9

Oregon Health & Science University, Medical Devices Deals, 2012 to YTD 2018 10

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

MediciNova Enters into Agreement with US Department of Veterans and Oregon Health & Science 12

Vir Biotechnology Expands Agreement with Oregon Health & Science University 13

NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 14

OncoResponse Enters into Agreement with OHSU Knight Cancer Institute 15

Cancer Research UK Enters into Research Agreement with OHSU Knight Cancer Institute 16

Immunovia Partners with OHSU Knight Cancer Institute 17

Salem Health to Form Joint Venture with Oregon Health & Science University 18

Oregon Health Enters Into Co-Development Agreement With Intel 19

Organovo Enters Into Co-Development Agreement With OHSU Knight Cancer Institute For Cancer Research 20

Legacy Health System Partners OHSU Knight Cancer Institute 21

Quickbeam Enters into Licensing Agreement with Oregon Health & Science University 22

Fennec Pharma Amends Licensing Agreement with Oregon Health & Science University 23

Oregon Health & Science University, Key Competitors 24

Oregon Health & Science University, Key Employees 25

Oregon Health & Science University, Other Locations 26

Oregon Health & Science University, Subsidiaries 26

Oregon Health & Science University, Joint Venture 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Oregon Health & Science University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Oregon Health & Science University (OHSU), a subsidiary of Oregon State University is an academic health center that provides medical education, research, patient care and community services. The center's educational institute offers undergraduate and graduate courses in anesthesiology, dermatology, neurology, psychiatry, periodontology and nursing. It grants doctoral degrees in medicine, dentistry and nursing. OHSU provides healthcare services such as bone and joint care, cancer care, heart care, neuroscience, pediatrics, spine care and women's health, among others. OHSU conducts research in disease areas including cancer, rare genetic disorders, diseases of the central nervous system, cardiovascular-related research and infectious disease. The center has campuses in Beaverton and Scappoose. OHSU is headquartered in Portland, Oregon, the US.

Oregon Health & Science University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Oregon Health & Science University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Oregon Health & Science University, Medical Devices Deals, 2012 to YTD 2018 10

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

MediciNova Enters into Agreement with US Department of Veterans and Oregon Health & Science 12

Vir Biotechnology Expands Agreement with Oregon Health & Science University 13

NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 14

OncoResponse Enters into Agreement with OHSU Knight Cancer Institute 15

Cancer Research UK Enters into Research Agreement with OHSU Knight Cancer Institute 16

Immunovia Partners with OHSU Knight Cancer Institute 17

Salem Health to Form Joint Venture with Oregon Health & Science University 18

Oregon Health Enters Into Co-Development Agreement With Intel 19

Organovo Enters Into Co-Development Agreement With OHSU Knight Cancer Institute For Cancer Research 20

Legacy Health System Partners OHSU Knight Cancer Institute 21

Licensing Agreements 22

Quickbeam Enters into Licensing Agreement with Oregon Health & Science University 22

Fennec Pharma Amends Licensing Agreement with Oregon Health & Science University 23

Oregon Health & Science University-Key Competitors 24

Oregon Health & Science University-Key Employees 25

Oregon Health & Science University-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Joint Venture 27

Recent Developments 28

Government and Public Interest 28

Sep 06, 2018: NIH taps OHSU to help improve reproductive health 28

Sep 04, 2018: Antioxidant reduces risk for second heart attack, stroke 29

May 25, 2018: OHSU awarded USD 6.1 million to help improve quality of life for those with chronic lung infection 30

May 23, 2018: Foundation for Anesthesia Education and Research Awards USD 1.4 million in Grants 31

May 02, 2018: AI better than most human experts at detecting cause of preemie blindness 34

Apr 09, 2018: An advance for precision medicine 36

Mar 06, 2018: Moving toward a future free of drug-induced hearing loss 37

Jan 17, 2018: Zika virus damages placenta, which may explain malformed babies 38

Oct 27, 2017: Johns Hopkins Partnering with Other Institutions to Create a National Center for Health Data 39

Oct 10, 2017: National MS Society Commits Nearly USD 14 Million to New Research to Stop Multiple Sclerosis, Restore Function and End MS Forever 40

Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 41

Sep 18, 2017: Study uncovers markers for severe form of multiple sclerosis 42

Sep 15, 2017: New funding to unite transatlantic forces for the early detection of cancer 43

Aug 02, 2017: Study in Nature demonstrates method for repairing genes in human embryos that prevents inherited diseases 44

May 08, 2017: BrightFocus Foundation Honors Five Researchers on Macular Degeneration and Glaucoma 46

Jan 30, 2017: New genome-mapping technique opens new avenues for precision medicine 47

Other Significant Developments 48

Sep 12, 2018: GE Healthcare to expand OHSU mission control capabilities to support sepsis patient care 48

May 28, 2018: Scientists expand genetic screening to include rare medical disorders 49

May 16, 2018: OHSU, UCF launch first U.S. clinical trial of 3D-printed prosthetics for children 50

Oct 18, 2017: Patients with Serious Mental Health Conditions Receive Preventive Care at Rates Similar to Those Without These Conditions 52

Appendix 53

Methodology 53

About GlobalData 53

Contact Us 53

Disclaimer 53


List Of Figure

List of Figures

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Oregon Health & Science University, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Oregon Health & Science University, Pharmaceuticals & Healthcare, Key Facts 2

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Oregon Health & Science University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Oregon Health & Science University, Deals By Therapy Area, 2012 to YTD 2018 9

Oregon Health & Science University, Medical Devices Deals, 2012 to YTD 2018 10

Oregon Health & Science University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

MediciNova Enters into Agreement with US Department of Veterans and Oregon Health & Science 12

Vir Biotechnology Expands Agreement with Oregon Health & Science University 13

NanoString Technologies Enters into Agreement with OHSU Knight Cancer Institute 14

OncoResponse Enters into Agreement with OHSU Knight Cancer Institute 15

Cancer Research UK Enters into Research Agreement with OHSU Knight Cancer Institute 16

Immunovia Partners with OHSU Knight Cancer Institute 17

Salem Health to Form Joint Venture with Oregon Health & Science University 18

Oregon Health Enters Into Co-Development Agreement With Intel 19

Organovo Enters Into Co-Development Agreement With OHSU Knight Cancer Institute For Cancer Research 20

Legacy Health System Partners OHSU Knight Cancer Institute 21

Quickbeam Enters into Licensing Agreement with Oregon Health & Science University 22

Fennec Pharma Amends Licensing Agreement with Oregon Health & Science University 23

Oregon Health & Science University, Key Competitors 24

Oregon Health & Science University, Key Employees 25

Oregon Health & Science University, Other Locations 26

Oregon Health & Science University, Subsidiaries 26

Oregon Health & Science University, Joint Venture 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Oregon Health & Science University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.